| CDDW 2001 |
CASL POSTER SESSION TUESDAY
Liver/Biliary Disorders
[142] HEPATOCELLULAR CARCINOMA
IN A TERTIARY HOSPITAL IN TORONTO ONTARIO. ETIOLOGY, CLINICAL FEATURES, TREATMENT AND
SURVIVAL
Izhar Levy1, Paul Greig2, Steven Gallinger3,
Murray Asch4, Josephine Chan1, Bernard Langer2, Morris
Sherman1
Departments of 1Medicine, 2Surgery Toronto General Hospital, and
Departments of 3Surgery and 4Radiology, Mount Sinai Hospital, and
the University of Toronto, Toronto, Ontario
[143] PREVALENCE AND RISK
FACTORS FOR HEPATITIS B IN 1000 UNIVERSITY STUDENTS IN TORONTO
Izhar Levy1, Dean Chen1, Mel Krajden2,
David Smith3, Morris Sherman1
1Department of Medicine, Toronto General Hospital and the University of
Toronto, Toronto, Ontario; 2Center for Disease Control Vancouver, British
Columbia and the University of British Columbia, Vancouver, British Columbia; 3Student
Health Service, The University of Toronto, Toronto, Ontario
[144] THE SEROPREVALENCE OF
HEPATITIS A VIRUS IN CANADA. A STUDY IN 1000 UNIVERSITY STUDENTS IN TORONTO, AND A REVIEW
OF HEPATITIS A SEROPREVALENCE IN 7448 CANADIAN PEOPLE
Izhar Levy1, Dean Chen1, Mel Krajden2,
David Smith3, Morris Sherman1
1Department of Medicine, Toronto General Hospital and the University of
Toronto, Toronto, Ontario; 2Center for Disease Control Vancouver, British
Columbia and the University of British Columbia, Vancouver, British Columbia; 3Student
Health Service, The University of Toronto, Toronto, Ontario
[145] EVOLUTION OF BLOOD
TRANSFUSION REQUIREMENTS FOR LIVER TRANSPLANTATION OVER THE PAST DECADE: ONE CENTER
EXPERIENCE
M Deschênes, M Al-Ali, S Bachman, J Barkun, M Fernandez, P Metrakos, J
Tchervenkov
Hôpital Royal Victoria, Montreal, Quebec
[146] HISTORICAL FEATURES ARE
POOR PREDICTORS OF LIVER FIBROSIS IN CANADIAN PATIENTS WITH CHRONIC HEPATITIS C
RP Myers, RJ Hilsden, SS Lee
Liver Unit, University of Calgary, Calgary, Alberta
[147] ELIMINATION OF
HYPERDYNAMIC CIRCULATION IN PORTAL HYPERTENSIVE RATS BY ANTISENSE C-FOS OLIGONUCLEOTIDE
INJECTION IN THE NUCLEUS TRACTUS SOLITARII
DS Song, KA Sharkey, SS Lee
Liver Unit and Neuroscience Research Group, University of Calgary, Calgary, Alberta
[148] INVOLVEMENT OF
CAPSAICIN-SENSITIVE PERIPHERAL AND CENTRAL NERVES IN CIRRHOTIC CARDIOVASCULAR DERANGEMENT
IN RATS
Y Li, DS Song, YK Zhang, SS Lee
Liver Unit, Gastrointestinal Research Group, The University of Calgary, Calgary,
Alberta
[149] DO H63D HOMOZYGOTES FOR
THE HEMOCHROMATOSIS GENE (HFE) DEVELOP HEMOCHROMATOSIS?
Paul C Adams, Subrata Chakrabarti
London Health Sciences Centre, London, Ontario
[150] PORTO-PULMONARY
HYPERTENSION IN DECOMPENSATED CIRRHOSIS WITH REFRACTORY ASCITES
FS Benjaminov1, K Sniderman2, S Siu3, P Li3,
M Prentice1, F Wong1
Divisions of 1Gastroenterology & 3Cardiology, Department of
Medicine and 2Department of Medical Imaging, University of Toronto, Toronto,
Ontario
[151] LATE ACUTE REJECTION
(LAR) REJECTION POST TRANSPLANT: THE WESTERN CANADA EXPERIENCE
A Ramji1, E Yoshida1, V Bain2, U
Steinbrecher1, N Kneteman2, C Scudamore1, M Ma2,
S Erb1, K Gutfreund2, A Shapiro2, S Issa2, S
Chung1, W Wong2
1University of British Columbia, Vancouver, British Columbia; 2University
of Alberta, Edmonton, Alberta
[152] A CROSS-SECTIONAL
ANALYSIS OF SEN VIRUS (SEN V) IN LIVER TRANSPLANT RECIPIENTS
EM Yoshida1, AK Buczkowski2, A Giulivi3, S
Zou3, LA Forrester3
Departments of 1Medicine and 2Surgery, University of British
Columbia, Vancouver, British Columbia; 3Bureau of Infectious Diseases, Health
Canada, Ottawa, Ontario
[153] MULTIATTRIBUTE ASSESSMENT
OF THE HEALTH STATUS OF SURVIVORS OF PEDIATRIC LIVER TRANSPLANT
SM Gilmour1, D Bellerose2, CM Robertson1
1Department of Pediatrics and 2Deparment of Surgery, Liver
Transplant Research, University of Alberta, Edmonton, Alberta
[154] SPONTANEOUS CLEARANCE OF
TRANSFUSIONAL AND COMMUNITY-ACQUIRED PEDIATRIC HEPATITIS C
LTF Yeung, EA Roberts
Department of Paediatrics, The Hospital for Sick Children, University of Toronto,
Toronto, Ontario
[155] A NOMOGRAM TO PREDICT
C282Y HEMOCHROMATOSIS BASED ON BAYES’ THEOREM
JS McGrath, PC Adams
Division of Gastroenterology, University of Western Ontario, London, Ontario
[156] METHOTREXATE
HEPATOTOXICITY IN RHEUMATOID ARTHRITIS – FAILURE OF AMERICAN COLLEGE OF RHEUMATOLOGY
(ACR) GUIDELINES TO IDENTIFY PATIENTS AT RISK
A Fu, DK Driman, JC Gregor
Division of Gastroenterology, University of Western Ontario, London, Ontario
[157] LAMIVUDINE AS A SINGLE
AGENT FOR THE PREVENTION OF RE-INFECTION OF THE HEPATIC ALLOGRAFT IN PATIENTS WITH
HBV-RELATED CIRRHOSIS: A 5-YEAR FOLLOW-UP
KS Gutfreund1, MM Ma1, WS Wong1, NM
Kneteman2, DLJ Tyrrell1,3, EM Yoshida4, VG Bain1
Departments of 1Medicine, 2Surgery, 3Medical
Microbiology and Immunology, University of Alberta, Edmonton, Alberta; 4Department
of Medicine, University of British Columbia, Vancouver, British Columbia
[158] AUTOIMMUNE HEPATITIS
FOLLOWING ACUTE DRUG INDUCED HEPATOTOXICITY BY CLARITHROMYCIN AND AMOXICILLIN
EC Lam1, LD Jewell2, KS Gutfreund1
Departments of 1Medicine and 2Pathology, University of Alberta,
Edmonton, Alberta
[159] FULMINANT HEPATITIS IN
MONTREAL: ETIOLOGY AND OUTCOME
G Tessier, E Villeneuve, JP Villeneuve
Division of Hepatology, Hôpital Saint-Luc du CHUM, Université de Montréal,
Montreal, Quebec
[160] EVALUATION OF THE
ANTI-APOPTOTIC EFFECT OF INSULIN ON HEPATOCYTES IN THE MODEL OF LEFT PORTAL VEIN LIGATION
IN THE RAT
J Tousignant, R Lapointe, C Éthier, B Rocheleau, M Bilodeau
Division of Hepatology, Hôpital St-Luc du CHUM, Université de Montréal, Montreal,
Quebec
[161] HEPATIC PHOSPHORUS-31
MAGNETIC RESONANCE SPECTROSCOPY: A NOVEL APPROACH TO MONITORING LIVER FUNCTION AND
REGENERATIVE ACTIVITY IN THE RAT
IR Corbin, R Buist, V Volotovskyy, J Peeling, M Zhang, GY Minuk
Liver Diseases Unit, Departments of Medicine and Pharmacology, University of Manitoba,
Winnipeg, Manitoba
[162] THE DETECTION OF SENV AND
SENV SUBTYPES C/H AND D BY GENERAL AND NESTED POLYMERASE CHAIN REACTION
H Kojima, KDE Kaita, GY Minuk
Liver Diseases Unit, University of Manitoba, Winnipeg, Manitoba
[163] HEPATORENAL SYNDROME:
PREDISPOSING AND PRECIPITATING FACTORS
Kym Watt, Gerald Minuk
Liver Diseases Unit, University of Manitoba, Winnipeg, Manitoba
[164] MUTATIONS TO THE HBV
GENOME DURING IMMUNOSUPPRESSIVE THERAPY AND THEIR ROLE IN REBOUND HEPATITIS
P Wong, S Wong, WWS Wong, M Zhang, GY Minuk
Liver Diseases Unit, Department of Medicine, University of Manitoba, Winnipeg,
Manitoba
[165] INCREASED PREVALENCE OF
HETEROZYGOSITY FOR A1 ANTITRYPSIN DEFICIENCY IN SEVERE CYSTIC FIBROSIS LIVER DISEASE
KJ Friedman1, SC Ling2, M Macek Jr4, AJ
Handler1, DR Mack5, JL Colombo5, H Vávrová4,
G Castaldo6,7, M Spina6,7, F Salvatore6, J Phillips3,
J Zielenski3, PR Durie3, LM Silverman1, MR Knowles1
1University of North Carolina, North Carolina, USA; 2Royal
Hospital for Sick Children, Glasgow, Scotland; 3Hospital for Sick Children,
Toronto, Ontario; 4Charles University, Prague, Czech Republic; 5University
of Nebraska, Omaha, Nebraska, USA; 6University of Naples, Naples, Italy; 7University
of Molise, Isernia, Italy
[166] ABNORMAL INTESTINAL
PERMEABILITY IN PRIMARY BILIARY CIRRHOSIS
J Feld, K Cauch-Dudek, JB Meddings, EJ Heathcote
Divisions of Gastroenterology, University of Toronto, Toronto, Ontario and University
of Calgary, Calgary, Alberta
[167] PRIMARY PREVENTION OF
ESOPHAGEAL VARICEAL BLEEDING: WHAT IS THE IDEAL THERAPY?
S Shulman, JC Gregor, PJ Marotta
Division of Gastroenterology, London Health Sciences Centre, University of Western
Ontario, London, Ontario
[168] LIVER TRANSPLANTATION
OFFERS EXCELLENT LONG-TERM SURVIVAL FOR BUDD-CHIARI SYNDROME
E Alhamar, CN Ghent, W Wall, PJ Marotta
Liver Unit, London Health Sciences Centre, London, Ontario
[169] PEDIATRIC LIVER
TRANSPLANTATION AT THE UNIVERSITY OF ALBERTA – THE FIRST 10 YEARS
LJ Smith, AB Jones, SM Gilmour, DL Sigalet, AMJ Shapiro, D Bigam, NM
Kneteman
Departments of Pediatrics and Surgery, University of Alberta, Edmonton, Alberta
[170] EVALUATING HEALTH RELATED
QUALITY OF LIFE USING UTILITY MEASUREMENTS FOR CHRONIC HEPATITIS C
RG Sy, JC Gregor, P Vandervoort, PJ Marotta, BG Feagan
Department of Medicine and Epidemiology and Biostatistics, University of Western
Ontario, London, Ontario
[171] MULTIPLE FOCAL NODULAR
HYPERPLASIA AND HEPATIC TELANGIECTASIAS: FORTUITOUS ASSOCIATION OR CAUSAL RELATIONSHIP
L D’Aoust, B Nguyen, A Roy, G Pomier-Layrargues
Liver Unit and Department of Surgery, Centre Hospitalier de l’Université de
Montréal, Hôpital Saint-Luc, Montréal, Québec
[172] RACIAL DIFFERENCES IN
CHRONIC HEPATITIS C VIRAL INFECTION: LIVER BIOPSY CORRELATIONS
Shahab Mehdizadeh, Ann Stoutenburg, Charlotte Ryan, Thomas Shaw-Stiffel
Departments of Pathology and Medicine, Strong Memorial Hospital, University of
Rochester, Rochester, New York, USA
[173] DECREASED HEPATIC T CELL
GLUCOCORTICOID RECEPTOR EXPRESSION IN EXPERIMENTAL CHOLANGITIS
K Tjandra, T Le, MG Swain
GIRG, University of Calgary, Calgary, Alberta
[174] A CASE OF PEDIATRIC ONSET
PRIMARY BILIARY CIRRHOSIS
Y Dahlan, V Bain, L Smith, D Simmonds
Division of Gastroenterology, University of Alberta, Edmonton, Alberta
[175] TRANSFORMING GROWTH
FACTOR BETA PROTECTS ACTIVATED HEPATIC STELLATE CELLS FROM APOPTOSIS
M Verma1, M Dragunow2, TC Peterson1,3
Departments of 3Medicine and 2Pharmacology, Dalhousie
University, Halifax, Nova Scotia, and 2Department of Pharmacology, University
of Auckland, Auckland, New Zealand
[176] ASSESSMENT OF THE
FIBROGENIC STIMULATION INDEX (FSI(R)) IN CHRONIC HCV PATIENTS
TC Peterson, KM Peltekian
Department of Medicine, Dalhousie University, Halifax, Nova Scotia
[177] EFFECT OF PENTOXIFYLLINE
AND METABOLITE-1 (R/S) ON FIBROBLAST PROLIFERATION AND COLLAGEN SYNTHESIS
JM Raoul1, J Pincock2, TC Peterson1,3
Departments of 3Medicine, 1Pharmacology, and 2Chemistry,
Dalhousie University, Halifax, Nova Scotia
[178] NONALCOHOLIC FATTY LIVER
DISEASE IN PATIENTS INVESTIGATED FOR ELEVATED LIVER ENZYMES
Krikor Kichian, Ross Mclean1, Leah M Gramlich, Vincent G Bain,
Robert J Bailey
Department of Medicine, Division of Gastroenterology, and 1The Department
of Pathology, University of Alberta, Edmonton, Alberta
[179] IS THE DEGREE OF
HEMOLYTIC ANEMIA DURING REBETRON THERAPY FOR HEPATITIS C PREDICTABLE AND PREVENTABLE?
M Alghamdi, S Patel, G Hirsch, D Dickey, C Johnstone, K Peltekian
Hepatology Services, Dalhousie University, Halifax, Nova Scotia
[180] SCREENING PATTERNS FOR
HEPATOCELLULAR CARCINOMA IN THE LOWER MAINLAND AREA OF BRITISH COLUMBIA
AA Weiss
British Columbia Cancer Agency, Vancouver, British Columbia
[181] POST TRANSPLANT
LYMPHOPROLIFERATIVE DISORDER (PTLD) IN LIVER TRANSPLANT PATIENTS
Jill Tinmouth, Atul Humar
Multi-Organ Transplant Program, University Health Network, University of Toronto,
Toronto, Ontario
[182] ROLE OF MITOCHONDRIA AND
IP3-SENSITIVE STORES IN ALTERED HEPATOCELLULAR CALCIUM HOMEOSTASIS AFTER COLD PRESERVATION
AND WARM REOXYGENATION
A Elimadi, PS Haddad
Membrane Transport Research Group and Depatment of Pharmacology, Université de
Montréal, Montreal, Quebec
[183] AN ENDOSCOPIC ANIMAL
MODEL OF SPHINCTER OF ODDI DYSFUNCTION (SOD)
Adrian W Bak, Rafael Perini, Marcelo Muscara, John L Wallace, Robert Hawes
Mucosal Inflammation Research Group, University of Calgary, Calgary Alberta and
Digestive Disease Center, Medical University of South Carolina, Charleston, South
Carolina, USA
[184] EARLY PHASE HEPATITIS C
VIRUS (HCV) LOAD RESPONSE TO INTERFERON/RIBAVIRIN THERAPY
FH Anderson, N Rock, L Walston, A Mak, K Gunadasa, P Cook, WD Hill, M
Krajden
Vancouver General Hospital, British Columbia Centre for Disease Control, University of
British Columbia, Vancouver, British Columbia